17 February, 2026

Continuity and Risk Mitigation Following Unexpected QPPV Resignation

An unexpected QPPV resignation can create immediate compliance risks and operational uncertainty. In South Africa, a pharmaceutical company faced a sudden gap in local pharmacovigilance oversight, requiring urgent action to avoid regulatory exposure and inspection risk.

This PrimeVigilance case study shows how rapid escalation and interim PV support ensured continuity, maintained compliance, and stabilized operations during a critical transition period.

Read this case study to learn more about:

  • How compliance was maintained after a sudden QPPV resignation

  • How interim local PV oversight was implemented quickly

  • How regulatory risk was minimized during transition

  • How structured handover ensured long-term stability

Please submit form to access content.


Discover how we can help you

Close Popup

This site uses cookies to personalise and customise your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Cloudflare
In order to use this website we use the following technically required cookies
  • __cfduid

Technical Cookies
In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Save
Accept all Services